| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 6.4 | 45.3 | 0.5 |
| Other income | 0.0 | 0.1 | 0.0 |
| Total income | 6.4 | 45.3 | 0.5 |
| Profit before exceptional items & tax | -0.3 | 0.2 | -1.0 |
| Profit before tax | -0.3 | 0.2 | -1.0 |
| Net profit | -0.5 | 0.2 | -1.0 |
| Operating margin | -4.7% | 0.4% | -200.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +1180.00% |
|---|
Source
Read the filing ↗
BSE results filing, NSE: VIVANZA. Figures extracted from the filing.
Vivanza Biosciences Ltd: key numbers
- Share price
- ₹1.77
- Market cap
- ₹7.08 Cr
- Revenue (annual)
- ₹115.9 Cr
- Net profit (annual)
- ₹0.39 Cr
- P/E (TTM)
- 15.6×Sector 50.4×
- Promoter holding
- 20.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vivanza Biosciences Ltd
All →
12:13 IST
BSE
Annual General Meeting
Vivanza Biosciences Annual General Meeting
Vivanza Biosciences has convened its 44th AGM on September 11, 2026 via VC/OAVM. Nine agenda items cover financial statements, director appointments, and borrowing limit approvals.
13:12 IST
BSE
Financial Results
Vivanza Biosciences Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
Vivanza Biosciences Ltd reported revenue from operations of ₹9.3 Cr (+4.5% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY